|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 124.40 PLN | +1.47% |
|
+1.30% | -8.66% |
| 05-27 | Scope Fluidics says Bacteromic granted U.S. patent 'microfluidic chip' | RE |
| 05-15 | Scope Fluidics Q1 net loss at 13.5 million zlotys | RE |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Innovations in The Field of Diagnostics and Health Protection | - | - | 404K | 516K | 131K | |||||
Total Assets | 41.31M | 52.73M | 346M | 101M | 173M | |||||
Interest Expense | -25 | -2.61M | -743K | -278K | -210K | |||||
Income Tax Expense | - | -1K | 69.05M | 129K | 19.98M | |||||
CAPEX | -484K | -4.91M | -155K | -1.93M | -3.24M | |||||
EBT | -7.42M | -11.72M | 395M | -18.66M | 85.4M | |||||
D&A | 986K | 414K | 664K | 1.08M | 1.51M | |||||
Operating Income | -7.43M | -10.25M | 393M | -28.68M | 77.05M | |||||
Net Income | -7.42M | -16.64M | 318M | -18.78M | 65.42M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Poland | - | - | 404K | 516K | 131K | |||||
Total Assets | 41.31M | 52.73M | 346M | 101M | 173M | |||||
Interest Expense | -25 | -2.61M | -743K | -278K | -210K | |||||
Income Tax Expense | - | -1K | 69.05M | 129K | 19.98M | |||||
D&A | 986K | 414K | 664K | 1.08M | 1.51M | |||||
CAPEX | -484K | -4.91M | -155K | -1.93M | -3.24M | |||||
Net Income | -7.42M | -16.64M | 318M | -18.78M | 65.42M | |||||
EBT | -7.42M | -11.72M | 395M | -18.66M | 85.4M | |||||
Operating Income | -7.43M | -10.25M | 393M | -28.68M | 77.05M |
- Stock Market
- Stocks
- SCP Stock
- Financials Scope Fluidics S.A.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
